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ARTICLE
Estimating Binding Afﬁ  nities of the Nicotinic Receptor for Low-efﬁ  cacy 
Ligands Using Mixtures of Agonists and Two-dimensional 
Concentration–Response Relationships
Yamini Purohit and Claudio Grosman
Department of Molecular and Integrative Physiology, Center for Biophysics and Computational Biology, 
and Neuroscience Program, University of Illinois at Urbana-Champaign, Urbana, IL 61801
The phenomenon of ligand-induced ion channel gating hinges upon the ability of a receptor channel to bind li-
gand molecules with conformation-specifi  c affi  nities. However, our understanding of this fundamental pheno-
menon is notably limited, not only because the changes in binding site structure and ligand conformation that 
occur upon gating are largely unknown but, also, because the strength of these ligand–receptor interactions are 
experimentally elusive. Both high- and low-effi  cacy ligands pose a number of analytical and experimental chal-
lenges that can render the estimation of their conformation-specifi  c binding affi  nities impossible. In this paper, we 
present a novel assay that overcomes some of the hurdles presented by weak agonists of the muscle nicotinic recep-
tor and allows the estimation of their closed-state affi  nities. The method, which we have termed the “activation-
competition” assay, consists of a single-channel concentration–response assay performed in the presence of a 
binary mixture of ligands of widely different effi  cacies. By plotting the channel response (i.e., the open probability) 
as a function of the concentration of each agonist in the mixture, interpreting the observed response in the frame-
work of a plausible kinetic scheme, and fi  tting the open probability surface with the corresponding function, the 
affi  nities of the closed receptor for the two agonists can be simultaneously extracted as free parameters. Here, we 
applied this methodology to estimate the closed-state affi  nity of the muscle nicotinic receptor for choline (a very 
weak agonist) using acetylcholine (ACh) as the partner in the mixture. We estimated the dissociation equilibrium 
constant of choline (KD) from the wild type’s closed state to be 4.1 ± 0.5 mM (and that of ACh to be 106 ± 6 μM). 
We also discuss the use of accurate estimates of affi  nities for low-effi  cacy agonists as a tool to discriminate between 
binding and gating effects of mutations, and in the context of the rational design of therapeutic drugs.
INTRODUCTION
The nicotinic acetylcholine receptor (AChR) is acti-
vated by a variety of naturally occurring and synthetic 
ligands. The surge in structural information about the 
AChR (Brejc et al., 2001; Miyazawa et al., 2003; Celie 
et al., 2004), the recognition of the involvement of nic-
otinic pathways in cognitive function and dysfunction 
(Levin and Simon, 1998; Hahn et al., 2003), and the 
consistently growing repertoire of subtype-specifi  c lig-
ands with therapeutic potential (Holladay et al., 1997; 
Romanelli and Gualtieri 2003; Bunnelle et al., 2004) 
inevitably call for a parallel development of rigorous 
functional assays.
From a thermodynamic standpoint, the function of 
  ligand-gated ion channels is relatively simple: the recep-
tor channel can interconvert among a discrete number 
of different conformations, and each of these can bind 
ligands with distinct affi  nities (Fig. 1). Thus, the equilib-
rium constant of the closedU open isomerization of 
the liganded form of a receptor (i.e., the “effi  cacy,” here 
denoted as θ2) can be viewed as dictated by the gating 
equilibrium constant of the unliganded receptor (θo), 
and the ratio of the affi  nities of the open (1/JD) and the 
closed (1/KD) states for the ligand in question (Monod 
et al., 1965; Karlin, 1967; Jackson 1984, 1994). In the 
case of a receptor with two transmitter binding sites, 
like the muscle AChR, we have:
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Hence, a physically meaningful description of the 
interaction between a receptor and a ligand should 
be expressed in terms of conformation-specifi  c ligand-
  dissociation equilibrium constants, rather than in terms 
of phenomenological descriptors such as EC50 values. 
Since it is currently unfeasible to “trap” the protein in 
one of its various conformations, though, such detailed 
information has been diffi  cult to obtain experimentally, 
and affi  nity measurements derived from, say, equilib-
rium binding assays only provide a weighted average of 
the different conformation-specifi  c affi  nities.
Electrophysiological recordings provide the only ex-
perimental means to estimate conformation-specifi  c 
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  affi  nities of ion channels for agonists. However, classi-
cal concentration–response relationships at the single-
  channel level (i.e., plots of equilibrium open probability 
vs. agonist concentration) and, more recently developed, 
global-fi  tting full-maximum-likelihood methods (i.e., es-
timation of agonist association and dissociation rate con-
stants from maximum-likelihood fi  ts of mechanisms to 
dwell-time series; Qin et al., 1996; Hatton et al., 2003) 
have limited applicability in the case of agonists with very 
high or very low effi  cacies. The affi  nity for high-  effi  cacy 
agonists cannot be easily extracted from concentration–
response curves because effi  cacy and affi  nity become in-
creasingly correlated as the effi  cacy increases (Fig. 2 A). 
In these cases, affi  nities cannot be easily extracted from 
global-fi  tting methods either because the proportion of 
missed events increases with the effi  cacy of the agonist 
(in the AChR, higher effi  cacies are associated with faster 
opening rate constants; Grosman et al., 2000b), and the 
ability to correct for these missed intervals has practical 
limits. The estimation of affi  nities for low-effi  cacy ago-
nists also poses some challenges, most notably (in the 
case of the AChR) the narrow range of concentrations 
over which clusters of single-channel openings can be 
defi  ned. This is because the small gating-equilibrium 
constant in the presence of low-effi  cacy agonists is due to 
a slow opening rate constant (rather than a fast closing 
rate constant; Grosman, et al., 2000b) and, thus, high 
concentrations are needed to elicit identifi  able clusters. 
The problem with using such high agonist concentra-
tions is that ACh-like molecules (i.e., quaternary ammo-
nium compounds or protonated tertiary amines) block 
the pore domain of the open channel often with an af-
fi  nity not much smaller than that of the closed-channel 
transmitter binding sites (1/KD). As a result, the limit on 
the highest concentration of ligand that can be tested, 
set by channel block, is not much higher than the low-
est concentration that is needed to elicit identifi  able 
clusters. Moreover, the open probability (Popen) values 
obtained in spite of these technical diffi  culties are so 
low that the patch-to-patch variation is often compara-
ble to their means and are, therefore, unreliable (Fig. 
2 B). Given that low-effi  cacy agonists constitute a sub-
stantial fraction of the known molecules that bind to, 
and activate nicotinic receptors, the lack of information 
about conformation-specifi  c affi  nities severely limits our 
insight into the structural determinants of binding and 
(liganded) gating. It is worth noting here that this im-
portant defi  ciency probably extends to all neurotrans-
mitter-gated ion channels (e.g., Erreger et al., 2004).
An equally important aspect of molecular recognition 
is the understanding of how the structure of the receptor 
itself, and changes to it, affects the affi  nities for ligands. 
In many cases, the effects of mutations on the AChR’s 
transmitter binding site affi   nities are investigated by 
analyzing single-channel recordings elicited in the pres-
ence of ACh. However, the validity of ACh as a sensitive 
functional probe is questionable in the case of “gain-
of-function” mutants that open faster than the wild type 
(a very common phenotype) because the wild-type open-
ing rate constant ( 50,000 s−1) is very close to the fast-
est transition rate that can practically be estimated with 
current methods of analysis ( 130,000 s−1; Burzomato 
et al., 2004). In such instances, the use of low-effi  cacy 
agonists becomes an appealing alternative (Grosman 
and Auerbach, 2000; Grosman et al., 2000a). For low-
  effi  cacy agonists to be useful in this context, however, 
the estimates of wild-type affi  nities are required. Again, 
this is another good reason why the development of as-
says aimed at estimating conformation-specifi  c affi  nities 
for low-effi  cacy agonists is of fundamental importance.
We present, here, the details of a novel single-channel 
based methodology, which we have termed the “activation-
competition assay,” that allows the  estimation of the 
closed state’s affi   nity for low-effi   cacy agonists. Since 
one of the major hurdles is the narrow range of con-
centrations over which single-channel clusters can be 
identifi  ed with these agonists, we reasoned that using 
a mixture of two ligands, a high-effi  cacy agonist and 
the low-  effi  cacy agonist of interest, could overcome this 
limitation.   Although low concentrations of low-effi  cacy 
agonists fail to elicit identifi  able clusters, low concen-
trations can be suffi  cient to displace high-effi  cacy lig-
ands from the transmitter binding sites and reduce 
the Popen in a detectable manner; this effectively wid-
ens the range of weak agonist concentrations that can 
be tested. By plotting the channel response (Popen) as 
a function of the   concentration of each agonist in the 
Figure 1.  Thermodynamic cycles and AChR function. An MWC-
type of kinetic scheme (Monod et al., 1965) applied to the par-
ticular case of the (muscle) AChR. C, O, and D denote the closed, 
open, and desensitized conformations of the channel, respectively. 
In this paper, we refer to the two types of nonconductive con-
formations (closed and desensitized), collectively, as shut states. 
A denotes an agonist molecule that can bind to the neurotransmit-
ter binding sites. The broken arrows indicate the uncertainty as to 
the extent to which recovery from desensitization of mono- and 
unliganded AChRs proceeds directly (Desensitized→Closed) or 
through an open-channel conformation (Desensitized→Open→
Closed). The cycle considered for arriving at Eq. 1 is displayed 
in bold.  Purohit and Grosman 721
binary   mixture, interpreting the observed response in 
the framework of a plausible kinetic scheme, and fi  tting 
the Popen surface with the corresponding function, the 
affi  nities of the closed AChR for the two agonists can be 
simultaneously extracted as free parameters. Here, we 
applied this methodology to study the activation of the 
adult mouse muscle AChR by its two endogenous lig-
ands of markedly different effi  cacies: ACh and choline. 
We estimated the dissociation equilibrium constants of 
ACh (KD, ACh) and choline (KD, Choline) from the trans-
mitter binding sites of the wild type’s closed state to be 
106 ± 6 μM and 4.1 ± 0.5 mM, respectively. Also, we 
present an example of the use of weak (or “partial”) 
agonists to probe the ligand binding properties of fast-
opening, gain-of-  function mutants.
MATERIALS AND METHODS
Heterologous Expression of Wild-type and 𝗂S269I AChRs
Adult mouse muscle AChR cDNA clones (Gardner, 1990; Sine, 
1993) were provided by S.M. Sine (Mayo Clinic, Rochester, NY) in 
the CMV-based expression vector pRBG4 (Lee et al., 1991). The 
αS269I mutation was introduced using the QuikChange Site-
  directed Mutagenesis Kit (Stratagene). The complete DNA se-
quences of all inserts were confi  rmed by dideoxy sequencing. 
HEK 293 cells were maintained in Dulbecco’s Modifi  ed Eagle 
  Medium (Invitrogen) at 37°C in a 5% CO2 incubator and were 
used for heterologous expression of wild-type and mutant AChRs. 
Approximately 24 h before transfection, HEK 293 cells were seeded 
onto 35-mm plastic culture dishes. The cells were transiently trans-
fected using the calcium-phosphate precipitation method, the 
  fi  nal transfection mixture containing (in mM) 140 NaCl, 0.75 
Na2HPO4, 125 CaCl2, 25 HEPES/NaOH, pH 7.05, and  1 μg of 
total cDNA per 35-mm dish. The transfection was allowed to pro-
ceed at 37°C for  15 h, after which the medium was changed.
Single-channel Recordings
Recordings were performed in the cell-attached confi  guration 
(Hamill et al., 1981) at  22°C,  24 h after changing the culture 
medium. Patch pipettes pulled from borosilicate capillaries 
(  Sutter Instruments) were coated with Sylgard (Dow Corning 
Corporation) and fi   re polished. Pipette resistances typically 
ranged between 8 and 10 MΩ. To maximize control on the volt-
age applied to the patch, a potassium-based bath solution was 
used. This solution, which was also used in the pipette, contained 
(in mM) 142 KCl, 5.4 NaCl, 1.8 CaCl2, 1.7 MgCl2, and 10 HEPES/
KOH, pH 7.4. In addition, the pipette solution contained the 
agonist(s) (ACh, choline, or both) at the indicated concentra-
tions. The chloride salts of ACh and choline were obtained from 
Sigma-Aldrich and were used without further purifi  cation. All 
other chemicals were obtained from Acros Organics.
For the activation-competition assay of the wild-type AChR, 
the concentration of ACh in the pipette solution was varied from 
0 to 200 μM, whereas that of choline was varied from 0 to 50 mM 
(  Table I). For the one-dimensional (1-D) concentration–response 
assay of the αS269I mutant, the concentration of choline in the pi-
pette solution was varied from 200 μM to 50 mM. Unless otherwise 
stated, the patch pipette was held at a potential of +100 mV (i.e., 
the transmembrane potential was −100 mV). Single-  channel cur-
rents were recorded using an Axopatch 200B amplifi  er (  Molecular 
Devices), stored in videotape format using a PCM-VCR combina-
tion (VR-10B, fc = 37 kHz; Instrutech Corporation), and digitized 
at 100 kHz (National Instruments card PCI-MIO-16E-4).
Data Analysis
Preprocessing.  The QuB suite of programs (www.qub.buffalo.
edu) was used for data analysis, in combination with subroutines 
developed in-house. As a fi  rst step, the digitized single-channel 
Figure 2.  Simulated 1-D concentration–response relationships 
for high- and low-effi  cacy agonists. (A) The different plots are 
concentration–response curves simulated according to the linear 
kinetic scheme shown in the inset (see Eq. 7). These six hypothet-
ical high-effi  cacy agonists have the same EC50 value (20 μM) but 
differ in their closed-state affi  nities (1/KD) and diliganded gating 
equilibrium constant values (θ2). Note that as the effi  cacy in-
creases (i.e., as the maximum Popen approaches unity), different 
combinations of KD and θ2 values make almost indistinguishable 
predictions. This, superimposed on the inherent patch-to-patch 
variation of the experimental observations, makes it impossible to 
simultaneously extract both parameters for high-effi  cacy agonists 
from this type of assay. This problem would be solved if the θ2 
value of the ligand in question were known from independent 
  experiments, so that its value can be fi  xed during the fi  t. However, 
the accurate estimation of θ2 values for high-effi  cacy agonists is 
not trivial. (B) These plots are also concentration–response curves 
simulated according to the kinetic scheme shown in the inset of A 
but, in this case, they correspond to four hypothetical low-effi  cacy 
agonists with the same gating equilibrium constant (θ2 = 0.05) 
and different KD values. The scatter plot superimposed on the 
simulated line plots corresponds to wild-type single-channel data 
obtained from 23 independent patches exposed to different con-
centrations of the low-effi  cacy agonist choline (θ2 = 0.035). Each 
data point corresponds to a different patch. Note that even 
though the four sets of simulated parameters make different pre-
dictions, the maximum Popen values are small and comparable to 
the typical patch-to-patch variation of the Popen estimates. This 
makes it practically impossible to extract the affi  nities for weak 
agonists from observations of this sort.722 Muscle AChR KD for Choline
recordings were inspected visually. Sections of the data with extra 
noise (e.g., arising from membrane instability), with simultaneous 
openings of more than one channel, or with endogenous channel 
activity were excluded from subsequent analyses.   Occasionally, 
some patches displayed a small fraction of clusters of openings 
with a Popen that differed considerably from that of the mean 
  behavior. These sections were also excluded from the present 
analysis. The remaining data were segmented into stretches no 
longer than 500 ms, and these were subjected to idealization 
  (effective bandwidth ≅ DC-18 kHz) using a segmental k-means 
method based on a hidden Markov modeling procedure (SKM 
option in QuB; Qin, 2004). Amplitudes of single-channel  currents, 
as well as the mean durations of all open and shut intervals within 
these segments, were also estimated during the idealization step. 
The resulting idealized segments were concatenated such that all 
excluded portions of the recording were considered as baseline. 
This ensured that all idealized openings retained their “positions” 
in real time. All idealized fi  les corresponding to recordings dis-
playing stable current amplitudes were channeled into the subse-
quent analytical procedures.
Cluster Identiﬁ  cation. Clusters of single-channel openings were 
defi  ned as series of openings separated by shuttings (i.e., sojourns 
in a nonconductive conformation) shorter than a critical time, tcrit. 
All shuttings shorter than tcrit were interpreted as sojourns in closed 
states, whereas all shuttings longer than tcrit were interpreted as 
  sojourns in desensitized states. However, due to the exponential 
nature of dwell-time distributions, no tcrit value can perfectly sepa-
rate “short” from “long” sojourns, and some misclassifi  cation is, 
therefore, inevitable. This is a well-recognized problem in single-
  channel analysis, and a number of approaches, which differ in the 
particular aspect of the misclassifi  cation that is controlled, have 
been suggested. We chose to use the general idea behind the cri-
terion proposed by Jackson et al. (1983), according to which tcrit 
is the time value that minimizes the fraction of misclassifi  ed shut-
tings. The fraction of events that are misclassifi  ed when making 
such a “brick-wall” cut to an exponential distribution is given by:
   (2)
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where a and τ denote the areas and time constants of the dwell-
time distribution, and tcrit denotes the time value used to make the 
“cut” between the mth and the (m + 1)th components of a total of 
n exponential components. The tcrit value that minimizes the frac-
tion of misclassifi  ed intervals in Eq. 2 can be found by numerically 
solving Eq. 3 (we used Maple 6.0 software; Waterloo Maple):
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A modifi  cation that we deemed necessary with respect to previ-
ous applications of this criterion is that, here, Eqs. 2 and 3 include 
the areas and time constants of all the components of the distri-
bution, not only those of the two components fl  anking the cut. 
Thus, the fi  rst term on the righthand side of Eq. 2 gives the frac-
tion of intervals that happen to be longer than tcrit despite belong-
ing to one of the components to the left of the cut (1 ≤ i ≤ m), 
whereas the second term gives the fraction of intervals that hap-
pen to be shorter than tcrit despite belonging to one of the compo-
nents to the right of the cut (m + 1 ≤ j ≤ n). To illustrate this 
procedure graphically, Eq. 2 is plotted in Fig. 3 for a shut-time dis-
tribution with simulated parameters.
Because kinetic models cannot be avoided in QuB, the parame-
ters of the probability density function (pdf) that best describes 
each shut-time distribution were computed from the estimates of 
transition rates with approximate allowance for missed events 
(Qin et al., 1996). In turn, these transition rates were estimated 
from maximum-likelihood fi  ts to each idealized sequence of dwell 
times using the MIL option in QuB (Qin et al., 1996). The kinetic 
schemes used in this step were not ascribed any particular physical 
meaning and were simply chosen so as to maximize the likelihood 
Figure 3.  Estimation of the critical time (tcrit) for cluster defi  ni-
tion. The black line plots the fraction of misclassifi  ed shuttings 
(Eq. 2) for a hypothetical shut-time distribution consisting of four 
components. The areas (ai) and time constants (τi) are: a1 = 0.7, 
τ1= 1.0 ms; a2 = 0.15, τ2 = 10.0 ms; a3 = 0.1, τ3 = 100.0 ms; and 
a4 = 0.05, τ4 = 1000.0 ms. If the cut were intended to separate 
shuttings belonging to component 1 from those belonging to 
components 2–4, then the time value that minimizes the frac-
tion of (inevitably) misclassifi  ed intervals (tcrit) can be calculated 
(Eq. 3) to be 4.16 ms (open circle). At t = 4.16 ms, the fraction of 
misclassifi  ed shuttings (black line) is at the minimum value of 
0.066. The red line gives the fraction of total shuttings that belong 
to component 1 and yet are misclassifi  ed as belonging to compo-
nents 2–4. The blue line gives the fraction of total shuttings that 
belong to components 2–4 and yet are misclassifi  ed as belonging 
to component 1. Note that at t = tcrit, the contributions of the 
red line and the blue line plots to the misclassifi  ed fraction are 
  different. This was also the case for all the experimentally ob-
tained distributions analyzed in this paper.
TABLE I
Composition of the Different Binary Mixtures of Agonists Used in the 
Activation-competition Assay
[ACh] (μM)
[Choline] 
(mM)
0 5 10 14 20 32 50 70 100 120 140 200
0 XXXXXXXX X X
0.2 X X X
0.5 X X X
1X X X
2X XXXXXXXX X
5X X X
10 X X X
14 X X X
2 0 X XX XXXXX X X
32 X X X
40 X X X
50 X X X  Purohit and Grosman 723
of the parameters. This procedure is justifi  ed insofar as we are not 
using the transition rates themselves but the time constants and 
areas calculated from them. It has been shown that kinetic models 
that include all possible shut state U open state transitions but do 
not allow for any shut state U shut state or open state U open 
state transition (sometimes referred to as “uncoupled” models) 
can be used to obtain the best possible fi  t to the idealized sequence 
of open and shut times (Kienker, 1989; Rothberg and Magleby, 
1998; Gil et al., 2001). However, the large number of free parame-
ters in these models (2 × number of shut states × number of open 
states, without imposing any detailed balance constraint) makes 
the fi  t with MIL (Qin et al., 1996) increasingly more diffi  cult as 
the number of states in the kinetic scheme increases. Most notably, 
the maximization algorithm becomes prone to get “trapped” in 
local maxima, an observation made by others as well (Qin, and 
Li, 2004). Empirically, we found that fi  ts of our data with linear, 
(shut state)n U (open state)m models, albeit attaining a lower maxi-
mum likelihood than uncoupled models with the same number of 
shut and open states, yielded areas and time constants that were 
very close to those obtained with the uncoupled model but were 
much less prone to technical problems. Hence, depending on the 
total number of states in the model, the transition rates of one or 
the other model were fi  tted to the dwell-time series using the full 
  maximum-interval-likelihood approach in QuB. The number of 
shut and open states that best describes the data was determined 
by applying the Schwarz criterion (one of several statistical  criteria; 
Schwarz, 1978), according to which every additional transition 
rate in the kinetic model is justifi  ed as long as it increases the maxi-
mum log-likelihood value by at least [ln(N)]/2, where N is the 
  total number of events in the dwell-time series after imposing the 
time resolution. The latter was 25 μs, for both open and shut 
times, for all analyzed dwell-time series. It is useful to note here 
that the pdf that results from applying the missed-event correction 
implemented in MIL (a fi   rst-order approximation; Roux and 
Sauvé, 1985; Qin et al., 1996) to the estimated transition rates re-
tains the form of a mixture of exponential densities with the same 
number of components as the perfect-  resolution pdf.
Fig. 4 shows examples of experimental shut-time distributions 
obtained over a range of ACh-choline concentrations. Since shut-
time distributions were typically best described by more than two 
components, and because time constants attributable to sojourns 
in closed states are not necessarily much shorter than those at-
tributable to dwells in desensitized conformations (especially at 
low agonist concentrations), the cut site was not always obvious. 
To facilitate this, we checked for consistency among the tcrit values 
estimated for different patches exposed to the same agonist 
Figure 4.  Examples of experimentally obtained shut-time distributions, and calculation of tcrit values. For each histogram, the red and 
blue lines are the mixtures of exponential densities corresponding to the components to either side of the cut (see Materials and Methods). 
It can be shown that the tcrit for any given distribution (open circles) coincides with the time value at which these two exponential den-
sities intersect (Eq. 3). The sum of the red and blue lines gives, of course, the mixture of exponential densities corresponding to all the 
components of the distribution (bear in mind, though, that the ordinates are plotted as the square root). The tcrit value, the total number 
of shuttings, and the fraction of misclassifi  ed shuttings in these example histograms are, respectively, as follows: A: 65.44 ms, 12,051, 
0.008; B: 15.92 ms, 19,664, 0.124; C: 45.03 ms, 19,239, 0.012; D: 5.40 ms, 45,564, 0.007; E: 5.14 ms, 34,274, 0.008; F: 12.41 ms, 4,029, 0.022; 
G: 1.09 ms, 40,149, 0.009, H: 1.99 ms, 29,204, 0.004, I: 4.28 ms, 4,707, 0.054.724 Muscle AChR KD for Choline
  solution and examined the trend in the tcrit values across the range 
of concentrations studied. For example, at a fi  xed concentration 
of choline (Table I), increasing concentrations of ACh are ex-
pected to increase the (intracluster) Popen and, thus, to reduce tcrit. 
At the fi  xed concentrations of ACh used here (Table I), on the 
other hand, increasing concentrations of choline are expected to 
decrease the Popen and, therefore, to increase tcrit. The tcrit values 
thus estimated were used to segment the idealized dwell-time se-
ries into clusters, but only those containing a minimum of fi  ve 
openings (and four closures) were retained for further analysis; 
we found that imposing this threshold was often necessary to 
eliminate openings of dubious origin. Intracluster open- and 
shut-interval durations of any given patch were averaged to calcu-
late their respective means (τopen and τclosed), which, after the appro-
priate corrections to account for channel block, were combined 
to calculate the mean intracluster Popen:
 
τ
ττ
open
open
open closed
P= .
+
 (4)
The reported Popen values and standard errors were calculated 
from the means of individual patches. In Figs. 5 and 6, we present 
examples of single-channel clusters identifi  ed using the proce-
dures discussed above.
Corrections for Block. At some of the concentrations employed in 
the assay, the interaction of both ACh (≥100 μM) and choline 
(≥1 mM) with the channel’s pore domain results in detectable 
channel block and in the ensuing distortion of the dwell-time distri-
butions. In the range of ACh concentrations tested here, channel 
block by ACh was manifest mainly as multiple brief shuttings which, 
in the absence of an appropriate correction, would be erroneously 
interpreted as closures. To alleviate the effect of this distortion, we as-
sumed that a time value, tblock, can be defi  ned such that all shuttings 
shorter than tblock correspond to blocking events, and all shuttings 
longer than this threshold (but shorter than tcrit) correspond to 
channel closures. tblock was calculated by applying Eqs. 2 and 3, as-
suming that most blocked sojourns are contained within the brief-
est shut-time component. The average tblock value across patches 
was  75 μs. Next, we modifi  ed the list of dwell times correspond-
ing to the individual clusters such that all shuttings shorter than 
tblock were “absorbed” by the fl  anking open-state sojourns, in an at-
tempt to make channel block “disappear.” Dwell times within these 
“corrected” clusters were then used to calculate, fi  rst, the mean 
open and closed times (τopen and τclosed) and, fi  nally, the Popen (Eq. 4). 
It should be noted that the Popen values so calculated are overes-
timated because closures briefer than tblock are also absorbed. For 
example, closures involving a single sojourn in the diliganded 
closed state have a mean lifetime of a few tens of microseconds, well 
below typical tblock values. Not correcting for ACh block at all, on 
the other hand, would have yielded underestimated Popen values.
Choline also blocks the AChR. However, individual choline 
block events could not be resolved as discrete shuttings (most 
likely owing to a much faster kinetics of binding/unbinding to/
from the pore). Instead, choline block was manifest as both, the 
attenuation of the single-channel current amplitude and as the 
prolongation of apparent open times (see Purohit and Grosman 
on p. 703 of this issue). The procedure followed to account for 
this prolongation (which, unless corrected, would have led to the 
overestimation of the Popen) is presented in detail in the accom-
panying paper (see Eqs. 6 and 7 in Purohit and Grosman, 2006). 
In brief, it consisted of dividing the observed mean open-time 
  values (τopen) by a factor that accounts for the slower shutting rate 
(a factor of  12) of choline-blocked channels:
  =
−
+
1
Prolongation factor ,
(1 F)
F
12
 (5)
Figure 5.  Wild-type AChR single-channel inward currents elicited by various concentrations of ACh (A) or choline (B). Membrane 
  potential ≅ −100 mV. Display fc ≅ 4 kHz. Openings are downward defl  ections. With the exception of the 200 μM and 2 mM choline 
traces (which are arbitrarily chosen sections of data), all stretches of currents are example clusters of single-channel openings identifi  ed 
as elaborated in Materials and Methods. In the presence of choline alone, clusters of openings could be identifi  ed only at [choline] ≥ 
14 mM. For display purposes only, the durations of plotted clusters are similar, but these do not refl  ect the mean cluster duration under 
each agonist condition. At the concentrations studied here, fast open-channel block by ACh is manifest as a concentration-dependent 
increase in the proportion of brief shuttings. Fast open-channel block by choline is manifest as a concentration-dependent decrease in 
the (apparent) single-channel current amplitude and as a prolongation of the (apparent) open times (Purohit and Grosman, 2006). 
Note the different time scales in A and B.  Purohit and Grosman 725
where F (the fractional current) is the single-channel current am-
plitude at each choline concentration normalized by the ampli-
tude measured at low, nonblocking concentrations. In the case of 
recordings made in the presence of mixtures of ACh and choline, 
the two corrections were applied sequentially.
Unlike the open-time distributions, the distributions of shut 
times were not corrected for channel block. Although the effect 
of block on the duration of shut intervals is more diffi  cult to 
  characterize than that on open intervals, we presented evidence 
(  Purohit and Grosman, 2006) for the notion that, at least in the 
range of choline concentrations used in these papers, the ob-
served choline-diliganded opening rate remains quite close to its 
expected value at zero concentration of blocker (i.e., the open-
ing rate constant of the choline-diliganded unblocked AChR). 
  Therefore, a correction was deemed unnecessary.
Constructing Concentration–Response Plots. Computed mean 
open (τopen) and mean closed times (τclosed), corrected for chan-
nel block as needed, were substituted into Eq. 4 to estimate the 
corresponding Popen values. For the activation-competition assay, 
the Popen was plotted as a function of the two independent vari-
ables, [ACh] and [choline]. The data were interpreted in the 
framework of the kinetic scheme in Fig. 7 and were fi  tted with 
Eq. 6 (see Results) using SigmaPlot software (SPSS). The trans-
mitter binding site affi  nities of the closed wild-type AChR for the 
two agonists were extracted as free parameters of this fi  t. In the 
case of the 1-D concentration–response analysis of the αS269I mu-
tant, the plot of Popen vs. [choline] was generated. The data were 
fi  tted with Eq. 7 (see Results), and the affi  nity of the closed αS269I 
AChR for choline was extracted as a free parameter of the fi  t.
Appraisal of the Methodology
One can defi  nitely think of simpler, more direct ways of deal-
ing with channel block. Instead of having to correct the data to 
  account for the distorting effects of block, one could have incor-
porated this phenomenon into the kinetic scheme in Fig. 7 and 
fi  tted the “crude” Popen values with the corresponding function. 
Exactly the same could be said of our way of classifying shut in-
tervals into closed and desensitized sojourns (for the identifi  ca-
tion of clusters of single-channel openings), which has always 
some error associated with it. However, accounting for channel 
block and desensitization explicitly in the kinetic model would 
have implied the inclusion of, at least, six more states to the 
reaction scheme (three open-blocked states and three desen-
sitized states; Fig. 7) and most likely many more (see below). 
This would have complicated Eq. 6 (by having at least six more 
Figure 6.  Example clusters of wild-type AChR single-channel inward currents elicited by mixtures of ACh and choline. (A) [ACh]: 
  variable; [Choline]: 2 mM. (B) [ACh]: variable; [Choline]: 20 mM. (C) [ACh]: 32 μM; [Choline]: variable. (D) [ACh]: 100 μM; [Choline]: 
  variable. Membrane potential ≅ −100 mV. Display fc ≅ 4 kHz. Openings are downwards. The durations of plotted clusters do not refl  ect 
the mean cluster duration under each agonist condition.726 Muscle AChR KD for Choline
  unknowns) to a point where the unknowns of interest (i.e., the 
closed-state affi  nities) might no longer be estimated reliably. 
These considerations led us to adopt the sequential approach 
presented here.
It could also be asked why the KD values for choline and ACh 
were not calculated from the rate constants of the kinetic scheme 
in Fig. 7, which, in turn, could have been estimated directly by ap-
plying a full-maximum-likelihood approach to the idealized series 
of openings and shutting within clusters. Our reason for not doing 
so is that fi  tting rate constants directly would have implied the use 
of a kinetic model that correctly accounts for block by the agonist 
itself. Since the closing rate constant of choline-blocked channels 
is not zero (i.e., a “linear” block model does not describe the data; 
Purohit and Grosman, 2006), a complete kinetic scheme should 
include a reaction step for the association/dissociation of choline 
to/from the closed-channel pore (not only to/from the open-
channel pore), and a step for the gating reaction of the choline-
blocked channel (not only of the unblocked channel) for, at least, 
each diliganded confi  guration of the receptor (i.e., choline dili-
ganded, ACh diliganded, and heterodiliganded). Similarly, reac-
tion steps should be added to represent block by ACh. Overall, 
this seems too complex a kinetic model for the transition rates to 
be estimated correctly; thus, we chose to extract Popen estimates 
and fi  t them with Eq. 6.
Recently, a full-maximum-likelihood approach (Qin et al., 
1996) was applied to data recorded from the mouse muscle AChR 
exposed to mixtures of carbachol and choline, using a kinetic 
model that does not account for channel block (Akk et al., 2005). 
The results from a number of patches were analyzed indepen-
dently, and a different KD value for choline was estimated for each 
of them. The average of the estimates for the wild-type AChR was 
 1.3 mM.
RESULTS
The Activation-competition Assay
The activation-competition assay introduced here can 
be regarded as a two-dimensional version of the more 
common, 1-D, single-channel concentration–response 
curve. The experimental estimation of binding affi  ni-
ties for low-effi  cacy agonists poses some challenges that 
cannot be easily overcome using standard approaches 
(Fig. 2 B). We found, however, that the use of binary 
mixtures of ligands containing the low-effi  cacy  ago-
nist of interest and a high-effi  cacy agonist (the affi  nity 
for which need not be known) is a simple “trick” that 
makes the estimation of affi  nities for weak agonists
  feasible. Fig. 8 illustrates this point graphically with 
simulated data. Unlike the plot in Fig. 2 B, the shape of 
the surface in Fig. 8 is clearly sensitive to the different 
affi  nities of the simulated low-effi  cacy agonists. Fig. 7 
shows the kinetic scheme we used to interpret the 
  activation-  competition assay, and Eq. 6 is the function 
that describes the Popen (i.e., the sum of the occupancy 
probabilities in OA2, OB2, and OAB) as a function of 
the concentrations of the two agonists in the mixture. 
In Eq. 6 (see above), A and B denote the concentrations 
of the two ligands in the mixture, KD,A and KD,B are their 
respective dissociation equilibrium constants from the 
closed-state transmitter binding sites, and θ2, ρ2, and η2 
are the gating equilibrium constants of the receptor 
doubly liganded with A, doubly liganded with B, or 
heterodiliganded (Fig. 7).
It is important to note, here, that the kinetic scheme 
in Fig. 7, and therefore Eq. 6, is based on a number 
of assumptions that are discussed and validated in the 
  Discussion: (a) that the two AChR transmitter bind-
ing sites are functionally equivalent and independent 
(at least in terms of their KD values), (b) that unli-
ganded and monoliganded openings of the wild-type 
AChR make a negligible contribution to the Popen, 
and (c) that the gating equilibrium constant of the 
ACh-  choline heterodiliganded receptor (η2) can be 
calculated as the geometric mean of the respective ho-
modiliganded gating equilibrium constants (θ2 and ρ2; 
Fig. 7).   Finally, desensitized states were not explicitly 
included in the model because sojourns in these states 
were considered to be excluded from the clusters of 
openings and closures that were fi  tted with Eq. 6 (see 
  Materials and Methods), and because the extent to 
which entry into desensitization shortens the lifetime 
of the open state is negligible in the wild-type AChR 
(Purohit and   Grosman, 2006). Likewise, blocked states 
were omitted from the scheme because their occurrence 
Figure 7.  Kinetic scheme used to interpret the activation-
  competition assay data. A and B denote the two agonists of differ-
ent effi  cacy present simultaneously during the assay. The two 
transmitter binding sites were assumed to have equivalent and in-
dependent KD values, whereas unliganded openings, monoligan-
ded openings, desensitized states, and blocked states were omitted 
(see Discussion for a justifi  cation). From the assumed equivalence 
and independence of the binding free energies associated to each 
binding site, the gating equilibrium constant of the heterodili-
ganded receptor was calculated as the geometric mean of the 
  experimentally estimated effi  cacies of the two agonists in the 
  mixture. The inset shows the defi  nitions of the equilibrium con-
stants in the model. This kinetic scheme is the same as that used 
by Liu and Dilger (1993) to study the activation of the muscle 
AChR by mixtures of decamethonium and ACh although, in 
our case, blocked states were not included; channel block was 
fully accounted for separately.  Purohit and Grosman 727
was   accounted for before the fi  tting with Eq. 6 (see 
  Materials and Methods).
Afﬁ  nities of the Closed Wild-type AChR for ACh 
and Choline
Encouraged by the simulations shown in Fig. 8, we em-
barked on applying the activation-competition assay 
to experimental data, with the goal of estimating the af-
fi  nity of the closed-AChR’s transmitter binding sites for 
choline, an endogenous low-effi  cacy agonist. Over 50 
agonist conditions were assayed (Table I), and the cor-
responding intracluster Popen values, averaged across 
different patches, were plotted as a function of the con-
centrations of choline and ACh (Fig. 9). To reduce the 
number of free parameters in Eq. 6, we fi  xed the values 
of the three gating equilibrium constants, (θ2, ρ2, and 
η2; Fig. 7) to their independently determined values. 
We fi  xed the value of θ2 (ACh-diliganded gating) to 25, 
on the basis of recent single-channel estimates (Hatton 
et al., 2003), although reported values range from 15 to 
50, approximately. We fi  xed ρ2 (choline-diliganded gat-
ing) to 0.035, as determined from the ratio of the open-
ing and closing rate constants of the choline-diliganded 
AChR ( 125 s−1 and  3,900 s−1, respectively; Purohit 
and Grosman, 2006). Lastly, we fi  xed η2 (heterodiligan-
ded gating) to (θ2ρ2)0.5 = 0.935, following the assump-
tion that the contributions of the two transmitter 
binding sites to the total binding free energy are equiva-
lent and independent of each other. To the extent that 
the heterodiliganded confi  guration cannot be isolated 
from the two homodiliganded forms, and that the con-
tribution of heterodiliganded open sojourns to the total 
Popen is small (see Figs. 13 and 14 in Discussion), the ex-
perimental estimation of η2 is not straightforward. 
Hence, we chose to calculate it.
The fi  t of the 2-D concentration–response surface in 
Fig. 9 with Eq. 6 yielded the dissociation equilibrium 
constants of ACh (KD, ACh) and choline (KD, Choline) from 
the wild-type AChR’s closed state. These values are 
106 ± 6 μM and 4.1 ± 0.5 mM, respectively. Thus, the 
affi  nity of the closed-state transmitter binding sites for 
ACh is larger than that for choline by a factor of  40.
To evaluate how sensitive the KD estimates are to the 
particular value assumed for θ2, we repeated the fi  tting 
procedure assuming different θ2 values ranging from 
5 to 100. Fig. 10 shows that KD, ACh estimates depend 
strongly on the particular value at which θ2 is fi  xed, 
ranging from 30.4 μM, at θ2 = 5, to 248 μM, at θ2 = 100. 
On the other hand, however, KD, Choline estimates are 
fairly consistent, ranging from 3.4 mM, at θ2 = 5, to 
4.4 mM, at θ2 = 100. We conclude that the extraction of 
KD values for low-effi  cacy agonists, using the activation-
competition assay, is robust even if the gating equilib-
rium constant of the high-effi  cacy partner in the mixture 
(which is generally diffi  cult to estimate accurately) is 
not known with certainty.
Afﬁ  nity of the Closed αS269I AChR for Choline
Although functional studies of site-directed mutants 
have become the staple fare of structure–function 
Figure 8.  Simulated plots illustrating 
the activation-competition assay. The 
different surfaces correspond to the ex-
pected responses in the presence of 
four hypothetical binary mixtures, con-
sisting of the same high-effi  cacy agonist 
and four different low-effi  cacy agonists. 
The plots were calculated in the con-
text of the kinetic scheme in Fig. 7, us-
ing Eq. 6. For the high-effi  cacy agonist, 
A, KD = 50 μM and θ2 = 100. The four 
low-effi  cacy agonists, B, have the same 
diliganded gating equilibrium constant 
(ρ2 = 0.2; see Fig. 7 for notation) but dif-
fer in their affi  nities. (A) KD,B = 10 μM. 
(B) KD,B = 100 μM. (C) KD,B = 1 mM. 
(D) KD,B = 10 mM. The plots illustrate 
the sensitivity of the “shape” of the sur-
face to differences in the affi  nities for 
low-effi  cacy agonists.728 Muscle AChR KD for Choline
  relationships in proteins, a clear identifi  cation of the 
functional aspect that is affected by any given mutation 
is rarely simple. In the particular case of ligand-gated 
ion channels, an increased diliganded gating equilib-
rium constant, for instance, could be due to an effect of 
the mutation on ligand binding (more specifi  cally on 
the affi  nity ratio KD/JD) and/or on unliganded gating 
(Fig. 1 and Eq. 1), and this distinction is absolutely nec-
essary if we want to understand how structure gives rise 
to function.
As an example, we analyzed the αS269I AChR, a re-
ceptor harboring a mutation in the (extracellular) M2–
M3 linker (Croxen et al., 1997). Because this mutant 
has a gain-of-function phenotype (Croxen et al., 1997; 
Grosman et al., 2000a), a high-effi  cacy ligand like ACh 
becomes an impractical tool to probe the effect of the 
mutation on ligand binding (Fig. 2 A) and, instead, a 
weak agonist like choline may be preferred (Grosman 
and Auerbach, 2000). Fig. 11 shows representative 
Figure 9. The  affi  nity of the wild-
type AChR’s closed state for choline. 
(A) Structures of choline and ACh. 
(B) The KD values for ACh and cho-
line were estimated by globally fi  t-
ting Eq. 6 to the entire experimental 
dataset of an activation-  competition 
assay. KD, ACh and KD, Choline were esti-
mated to be 106 ± 6 μM, and 4.1 ± 
0.5 mM, respectively. The other 
parameters in Eq. 6 were fi  xed as 
follows:  θ2  = 25, ρ2 = 0.035, and 
η2 = (θ2ρ2)0.5 = 0.935. Two views of 
the same 3-D plot, rotated by 100°, 
are shown. (C) Data displayed as 
1-D concentration–  response plots, 
with the concentration of choline 
in the pipette fi  xed at the indicated 
values. Note that the solid lines were 
calculated using the parameters ob-
tained from the global fi  t. (D) Data 
displayed as 1-D concentration–
  response plots, with the concentra-
tion of ACh in the pipette fi  xed at 
the indicated values. The solid lines 
were calculated using the param-
eters obtained from the global fi  t. 
Vertical error bars in C and D are 
standard errors.
  single-channel clusters of openings in the presence of 
increasing concentrations of choline alone. The use of 
binary mixtures of ligands was not necessary because 
the effi  cacy (θ2) of choline on this mutant is such that 
the limitations that apply to very high and very low effi  -
cacy agonists (Fig. 2), and which prompted the develop-
ment of the activation-competition assay, do not hold 
for this receptor–ligand pair. Fig. 12 shows the (1-D) 
concentration–response relationship obtained after ap-
plying the appropriate corrections for choline block to 
single-channel clusters identifi   ed following the same 
procedures as for the wild type. The Popen curve was fi  t-
ted with Eq. 7, the one-agonist-only version of Eq. 6. 
That is, Eq. 7 assumes that the two transmitter binding 
sites have equivalent and independent KD values, that de-
sensitization shortens the lifetime of this mutant’s open 
state to a negligible extent, and that the contribution of 
unliganded and monoliganded openings to the total Popen 
(in the 500 μM to 50 mM choline   concentration range   Purohit and Grosman 729
used here) is negligible, even when the unliganded gat-
ing equilibrium constant of this mutant is larger than 
the wild type’s (Grosman, 2003):
  =
+
+
θ
open 2
D
2
2
1
P,
(K A)
1
A
 (7)
where A denotes the concentration of choline, KD is 
the choline dissociation equilibrium constant from the 
closed-state transmitter binding sites, and θ2 is the 
  choline-diliganded gating equilibrium constant. The fi  t of 
the 1-D concentration–response curve shown in Fig. 12 
with Eq. 7 (solid black line), with both KD and θ2 set as 
free parameters, yielded KD = 2.6 ± 0.5 mM and θ2 = 
2.6 ± 0.3. Thus, the  75-fold increase in the choline-
  diliganded gating equilibrium constant caused by the 
αS269I mutation (2.6/0.035 ≅ 74), is accompanied by 
only a modest change in the closed-state affi  nity for cho-
line (2.6 versus 4.1 mM). The increased θ2 value of the 
mutant must then be due to a higher open-state affi  nity 
for choline (i.e., a lower JD value) and/or a larger unli-
ganded gating equilibrium constant (Fig. 1 and Eq. 1). 
If one could experimentally estimate JD, then one could 
calculate the unliganded gating equilibrium constant 
applying Eq. 1. Conversely, if one could experimentally 
estimate the unliganded gating equilibrium constant, 
one could calculate JD. Doing this would provide us with 
a more complete picture of the functional consequences 
of the αS269I mutation.
Afﬁ  nity of the Open αS269I AChR for Choline
Unlike KD values, JD values of the AChR cannot be es-
timated directly from single-channel concentration–
  response data. The reason for this is clearly illustrated 
by Eq. 8. Considering the upper half of the kinetic 
scheme in Fig. 1, that is, the three closed states (C, CA, 
and CA2) and the three open states (O, OA, and OA2), 
and expressing the unliganded and monoliganded gat-
ing equilibrium constants in terms of all other equilib-
rium constants in the scheme, the Popen due to the three 
open states is given by:
 
θ
open 2
D
2
D2
1
P= .
(K +A)
1+
(J +A)
 (8)
From this expression, and remembering that for ago-
nists KD > JD (in the case of ACh, for example, KD ≅ 
100 μM, and JD should be a few nanomolar), it   follows 
Figure 10.  Sensitivity of closed state affi  nity estimates to assump-
tions. The estimation of KD, ACh and KD, Choline, shown in Fig. 9, was 
based on a number of assumptions. Here, we tested the sensitivity 
of these estimates to the particular value of ACh-diliganded gat-
ing equilibrium constant (θ2) assumed. We refi  tted the Popen vs. 
concentration data (Fig. 9) with θ2 fi  xed at values between 5 and 
100. The values of the choline-diliganded (ρ2) and the heterodili-
ganded (η2) gating equilibrium constants remained fi  xed at 0.035 
and (θ2ρ2)0.5, respectively, as in Fig. 9. These plots show that the 
KD, ACh estimate is strongly correlated with the value at which θ2 is 
fi  xed (A), and that the KD, Choline estimate is, in contrast, quite 
  robust (B). The black circles denote the KD estimates at θ2 = 25, 
a very likely value for this gating equilibrium constant. The cor-
relation between effi  cacy and affi  nity for ACh illustrated in A is 
the same correlation illustrated in the simulated 1-D concentra-
tion–response curve of Fig. 2 A for high-effi  cacy agonists in gen-
eral. The activation-competition assay does not overcome this 
problem; that is why we propose the use of this novel approach as 
a tool to estimate the affi  nities for low-effi  cacy ligands. Note the 
different scales on the y axes in A and B. In the inset, the y axis in B 
is magnifi  ed.
Figure 11.  Example clusters of αS269I AChR single-channel in-
ward currents elicited by various concentrations of choline. Mem-
brane potential ≅ −100 mV. Display fc ≅ 4 kHz. Openings are 
downwards. Clusters were identifi  ed as described in Materials and 
Methods. Note that, since fast open-channel block by choline re-
sults in a concentration-dependent prolongation of the (apparent) 
open times (Purohit and Grosman, 2006), the intracluster Popen 
“looks” higher than it actually is.730 Muscle AChR KD for Choline
that if intracluster Popen values could be measured at 
very low agonist concentrations (comparable to or even 
lower than JD), then both KD and JD values could be ex-
perimentally estimated. However, the lowest concentra-
tion of agonist that is needed to elicit identifi  able 
clusters is generally much higher than the correspond-
ing JD value. For instance, as much as 10 μM ACh was 
needed in this study to elicit clear clusters of wild-type 
AChR openings, and as much as 14 mM was needed in 
the case of choline (the JD of which should be in the mi-
cromolar range). As a result, JD + A ≅ A, and Eq. 8 be-
comes Eq. 7, which does not depend on JD. Hence, 
experimentally obtained concentration–response assays 
do not provide any information about the affi  nity of the 
open-state transmitter binding sites for agonists. Simi-
larly, the impossibility of identifying clusters of unligan-
ded openings arising from individual channels precludes 
the direct estimation of the unliganded gating equilib-
rium constant (θo) from recordings made in the ab-
sence of agonist.
An alternative approach is to estimate θo from mea-
surements of the Popen in the absence of agonist in 
patches with a known number of channels; this can be 
achieved in fast-perfused outside-out patches.   Following 
this procedure, our estimate of θo for the αS269I mu-
tant is (2.3 ± 0.3) 10−6 (unpublished data). Therefore, 
applying Eq. 1, JD, Choline = 2.4 μM. Thus, the affi  nity of 
this mutant for choline increases by a factor of  1,000 
upon opening (KD, Choline/JD, Choline = 2.6 mM/2.4 μM). 
However, before we can estimate the extent to which 
the open-state affi  nity and the unliganded gating equi-
librium constant are affected by the αS269I mutation, 
we will have to estimate the wild-type value of θo, and 
then calculate the wild-type value of JD, Choline. This re-
quires a more elaborate experimental assay because the 
low wild-type unliganded Popen can hardly be measured 
under our experimental conditions.
DISCUSSION
The Afﬁ  nity for Low-efﬁ  cacy Ligands: An Experimentally 
Elusive Parameter
However paradoxical it may seem at fi  rst glance, the af-
fi  nities of ligand-gated ion channels for agonists are 
largely unknown. As elaborated above, this is due to a 
number of experimental and analytical hurdles, and 
the main goal of this paper was, precisely, to provide a 
means to overcome some of these diffi  culties. The acti-
vation-competition assay presented here is a novel, 2-D 
concentration–response assay that enables the simulta-
neous estimation of the affi  nities of the closed-channel 
receptor for a pair of agonists. Although the method 
can, in principle, be applied to extract the KD values for 
the two members of the pair, we envisage that it will be 
particularly useful for the estimation of affi  nities for 
low-effi  cacy agonists because it is the challenges posed 
by the latter that are specifi  cally addressed by this new 
approach. In the present study, we estimated the KD for 
choline, a low-effi  cacy agonist of the AChR, using ACh 
as the high-effi  cacy partner in the mixture.
The Popen vs. concentration data were interpreted in 
the framework of the kinetic scheme in Fig. 7, which is 
based on a set of assumptions. First, we assumed the 
functional equivalence and independence of the two 
transmitter binding sites. Although the α-δ and α-ε/γ 
agonist binding sites are structurally distinct, their func-
tional equivalence (in terms of their respective KD values) 
continues to be an unresolved issue (e.g., Sine et al., 
1990; Zhang et al., 1995; Wang et al., 1997; Salamone 
et al., 1999; Hatton et al., 2003). Reports based on 
the application of global, maximum-likelihood fi  ts to 
(  idealized) adult mouse muscle AChR single-channel 
currents (using the QuB suite of programs; Qin et al., 
1996) have lately suggested that the two binding sites 
have indistinguishable closed-state affi   nities for ACh 
(Salamone et al., 1999), whereas a more recent, compa-
rable analysis of the human counterpart (using the 
HJCFIT method; Colquhoun et al., 2003) suggested 
that the affi  nities are different (Hatton et al., 2003). 
The extent to which this discrepancy refl  ects genuine 
Figure 12. The  affi  nity of the αS269I AChR’s closed state for cho-
line. The KD value for choline was estimated by fi  tting Eq. 7 (black 
solid line) to the experimental data of a 1-D concentration–
  response assay (mixtures of agonists were not necessary here). 
Both KD, Choline and θ2 were set as free parameters and were esti-
mated to be 2.6 ± 0.5 mM, and 2.6 ± 0.3, respectively. Eq. 7 as-
sumes that both transmitter binding sites have equivalent and 
independent KD values. The data were also fi  tted with Eqs. 10–12, 
and the estimated parameter values are given in Table II. Eq. 10 
(red solid line) assumes that the binding sites are different and 
independent, Eq. 11 (blue dashed line) assumes that the binding 
sites are equivalent and interacting, and Eq. 12 assumes that the 
binding sites are different and interacting. The fi  ts with these 
three expressions are almost indistinguishable. The fi  t with Eq. 12 
(not shown for clarity) yielded KD estimates that were very sensi-
tive to the initial guesses and were very poorly defi  ned (i.e., the 
coeffi  cients of variation were very large). Vertical error bars are 
standard errors.  Purohit and Grosman 731
differences between species or differences in the ana-
lytical methods employed remains an open question. 
In the particular case of our activation-competition as-
say, the assumption of equivalence and independence 
of the transmitter binding sites turned out to be conve-
nient because it reduces the number of free parameters 
in Eq. 6 to a manageable level. But if the sites were nei-
ther equivalent nor independent of one another, what 
are we measuring then? For simplicity, we tested the 
equivalence/independence assumption on the concen-
tration–response data gathered from the αS269I mu-
tant activated (only) by choline. The results of fi  tting 
the four possible models (equivalent/independent, 
equivalent/interacting, different/independent, and 
different/interacting; see Appendix) are shown in Fig. 
12 and Table II. We conclude that, for all four models, 
a set of parameters can be found that describes very 
closely the equilibrium concentration–response curve 
of the αS269I AChR. Under the assumption of equiva-
lence and independence, though, the model is simplest, 
and the parameter estimates are most uniquely defi  ned. 
It is evident that observables other than the Popen, more 
sensitive to the different predictions made by the differ-
ent models, need to be analyzed before we can settle 
this vexed question on the basis of a criterion more 
compelling than that of parsimony. It is our impression 
that the application of global-fi  tting maximum-likeli-
hood methods has not been completely successful in 
this regard either.
Second, we ignored the occurrence of unliganded 
and monoliganded openings. This is justifi  ed because 
in the wild-type, the corresponding gating equilibrium 
constants are so small that the contribution of sojourns 
in the unliganded or monoliganded open states to the 
total Popen is negligible at the concentrations of agonist 
used here to elicit clusters. Even in the absence of a fi  rm 
estimate, the θo value of the wild-type AChR can be 
safely assumed to be in the 10−7–10−8 range. From Fig. 1, 
then, the ACh-monoliganded θ1 value (θ1 = [θ0θ2]0.5) 
should be close to 10−3, whereas the choline-monoli-
ganded  θ1 value should be in the 10−4–10−5 range. 
These values are, indeed, small.
Finally, the gating equilibrium constant of the ACh-
choline heterodiliganded receptor (η2) was fi  xed to the 
geometric mean of the respective homodiliganded gat-
ing equilibrium constants (θ2 and ρ2). When η2 was al-
lowed to vary during the fi  tting procedure, the free 
parameters were estimated to be: KD, ACh = 108 ± 6 μM, 
KD, Choline = 2.3 ± 0.7 mM, and η2 = 3.1 ± 1.0. Reassur-
ingly, these values compare well with the estimates of 
KD, ACh = 106 ± 6 μM and KD, Choline = 4.1 ± 0.5 mM, 
  obtained with η2 constrained to its calculated value of 
0.935. However, because we fi  nd no obvious evidence 
for deviations from the assumption of equivalence and 
independence of the two transmitter binding sites (in 
terms of their contributions to the total binding free 
energy), we take 106 ± 6 μM and 4.1 ± 0.5 mM as the 
ACh and choline dissociation equilibrium constants, 
  respectively, from the wild-type AChR in the closed state. 
It is likely that the difference between the calculated 
and fi  tted values of η2 refl  ects the inherent inaccuracies 
of the experimental data, and the notion that heterodi-
liganded receptors do not contribute much to the ob-
served Popen. Figs. 13 and 14 illustrate the contribution 
of the heterodiliganded and the two homodiliganded 
forms of the receptor to the total Popen.
Conformation-speciﬁ  c Afﬁ  nities: Basic 
and Applied Implications
Understanding the structural basis of a ligand’s differen-
tial binding to the open and closed forms of a receptor 
channel represents a large fraction of all we need to know 
to understand diliganded gating; the rest is unliganded 
gating. Thus, it is of obvious importance to be able 
to   obtain accurate estimates of conformation-  specifi  c 
  affi   nities. We envision that continued application of 
the activation-competition assay (to estimate KD values), 
along with fi  rm estimates of wild-type and mutant unli-
ganded gating equilibrium constants (to calculate JD 
  values), will pave our way toward this paramount goal.
In this paper, we focused on ACh and choline. From 
their respective θ2 estimates, it can be inferred (Eq. 1) 
that the increase in affi  nity for choline upon opening is 
smaller than that for ACh by a factor of  25 ([θ2, ACh/
θ2, Choline]0.5). Because the affi  nity of the AChR’s closed 
state (1/KD) for choline is lower than that for ACh by 
a factor of  40 (KD, Choline/KD, ACh), it follows that the 
TABLE II
Estimates of KD and θ2 Values for the Choline–αS269I AChR 
Ligand–Receptor Pair
Binding site properties Estimate (mean ± SEM) C.V. (%)
Equivalent and independent 
  (Eq. 7 or 9)
KD = 2.58 ± 0.46 mM 17.64
θ2 = 2.65 ± 0.31 11.53
Different and independent 
 (Eq.  10)
KDA = 0.19 ± 0.44 mM 228.5
KDB = 9.47 ± 4.81 mM 50.73
θ2 = 3.13 ± 0.62 19.97
Equivalent and interacting 
 (Eq.  11)
KMONO = 0.36 ± 0.80 mM 222.7
KDOUBLY = 4.9 ± 2.25 mM 46.15
θ2 = 3.13 ± 0.63 20.1
KD (dissociation equilibrium constant) and θ2 (diliganded gating equilibrium 
constant) values were estimated by fi  tting the appropriate expressions 
(see Appendix) to the Popen data in Fig. 12. Note the high coeffi  cients of 
variation (C.V.) associated with the KD estimates obtained by fi  tting the data 
with Eqs. 10 and 11. The estimates obtained by fi  tting the data with Eq. 12 
(which assumes that the binding sites are different and interacting) are 
even more ill defi  ned, and were highly sensitive to the initial guesses; thus, 
they are not included here. A model that assumes the equivalence and 
independence of the KD values of the two transmitter binding sites offers 
the most parsimonious explanation to our observations.732 Muscle AChR KD for Choline
  affi  nity of the open state (1/JD) for choline must be 
lower than that for ACh by a factor of  1,000 ([θ2, ACh/
θ2, Choline)0.5 (KD, Choline/KD, ACh]). Comparatively, then, it 
is not the binding to the closed state, but the binding to 
the open state, that is most different between choline 
and ACh. This highlights the importance of obtaining 
conformation-specifi   c structural data on the AChR’s 
transmitter binding sites.
From a more practical perspective, we anticipate that 
improved methodologies to estimate conformation-
  specifi  c affi  nities will contribute to further rationalize 
the process of structure-based drug design in, at least, 
two ways: fi  rst, by providing benchmark affi  nity values 
against which the robustness of computational ap-
proaches aimed at predicting ligand–protein binding 
affi  nities (Morreale et al., 2002; Oostenbrink and van 
Gunsteren, 2005; Woo and Roux, 2005) can be tested; 
and second, by providing a “library” of KD, JD, and effi  -
cacy values (θ2) that can guide efforts in medicinal 
chemistry toward the design of ligands with the desired 
properties (Holladay et al., 1997). In this respect, how-
ever, a caveat is in order: what does an experimentally 
estimated KD value really measure? What happens dur-
ing a ligand association/dissociation reaction? It is al-
most certain that binding reactions not only consist of 
the docking of a ligand to a binding site but, also, in-
volve local rearrangements in the protein, and changes 
in the conformation of the ligand, that precede the 
more global conformational change that accompanies 
gating. Thus, an experimentally obtained KD value 
would be the equilibrium constant of this complex re-
action, which, at least in the muscle AChR, can still be 
kinetically modeled as a one-step event (e.g., Salamone 
et al., 1999; Hatton et al., 2003; but see Burzomato et al., 
2004, for a probably different situation in the α1β gly-
cine receptor). It is obvious, then, that for computa-
tional approaches to make accurate predictions of 
measured binding affi  nities, the conformational fl  exi-
bility of both protein and ligand needs to be fully ac-
counted for in the algorithms. This is not an easy task, 
however, and constitutes one of the major roadblocks 
on the way toward the computer-aided rational design 
of drugs (Teague, 2003).
Low-efﬁ  cacy Agonists as Tools in Structure–Function Studies
Although the functional consequences of mutations to 
ligand-gated ion channels are typically classifi  ed into 
“binding” or “gating” effects, we think that it is more 
sensible to distinguish among effects on the closed-
state affi  nity, the open-state affi  nity, or the unliganded-
gating equilibrium constant (Eq. 1). Also, although 
most functional studies of AChR mutants use ACh as 
the ligand (with the understandable justifi  cation that 
ACh is the natural agonist of this receptor), we think 
that low-effi  cacy agonists, like choline, offer some im-
portant advantages in the case of fast-opening mutants. 
In the specifi  c case of the αS269I mutation studied 
here, we can conclude that the closed-state affi  nity for 
choline remains practically the same upon mutation 
(2.6 ± 0.5 mM in the mutant and 4.1 ± 0.5 mM in 
the wild type). If the open-state affi  nity also remained 
largely unaffected by the mutation, then the increase 
in the choline-diliganded gating equilibrium constant 
of the αS269I AChR (2.6 in the mutant and 0.035 in 
the wild type) would be entirely due to the increased 
unliganded activity (Eq. 1) reported earlier for this 
Figure 13.  Contribution of homodi-
liganded and heterodiliganded open 
probabilities to the total Popen in the 
presence of a binary mixture of agonists. 
The Popen due to all three open confi  gu-
rations in Fig. 7 is given by the sum of 
their respective individual occupancy 
probabilities. The wild-type KD, ACh and 
KD, Choline values, estimated as illustrated 
in Fig. 9, were used, along with the inde-
pendently estimated values of the three 
gating equilibrium constants, to calcu-
late (A) the total Popen; (B) the prob-
ability of the AChR being open and 
diliganded with ACh (POA2); (C) the 
probability of the AChR being open and 
diliganded with choline (POB2); and 
(D) the probability of the AChR being 
open and diliganded with one molecule 
of ACh and one of choline (POAB). In 
the wild-type receptor, there is an upper 
limit for the latter of  0.13.  Purohit and Grosman 733
mutant (Grosman, 2003).   However, because it is still 
not known how to predict changes in JD on the basis of 
measured changes in KD, we cannot offer a more com-
plete description of what goes wrong upon the αS269I 
mutation, at this point. Indeed, what we need to revert 
this situation is a robust estimate of the wild-type unli-
ganded gating equilibrium constant.
In spite of the many available weak agonists of the 
AChR, only choline seems to have met the requirements 
for a convenient functional probe of gain-of-function 
mutations, thus far. That is, high solubility, structural 
resemblance to ACh, manageable channel block, and 
binding/gating properties that can be reliably quanti-
fi  ed in the wild-type receptor. It may be noted that some 
mutations may speed up opening to  such an extent that 
choline may no longer be a useful probe. It is evident 
that to address these important cases, a wider repertoire 
of well-characterized low-effi  cacy agonists is needed.
APPENDIX
We tested the assumption that the two AChR trans-
mitter binding sites are functionally equivalent and in-
dependent (in terms of their KD values) by fi  tting the 
αS269I–choline one-dimensional single-channel Popen 
curve with the four possible models. We tested this as-
sumption on the αS269I mutant, rather than on the 
wild type, because the interaction between this mutant 
and choline can be characterized with a simple 1-D 
  concentration–response relationship (Fig. 12), which 
greatly facilitates the analysis.
For a receptor with two binding sites, and in the pres-
ence of a single ligand, the most general kinetic scheme 
(omitting unliganded openings, monoliganded open-
ings, and desensitized and blocked states) is given in 
Fig. 15. The properties of equivalence and indepen-
dence of the transmitter binding sites can be combined 
to give rise to four models, each of which is character-
ized by a different Popen expression.
If the two binding sites are equivalent and indepen-
dent, then (Fig. 15) KD1 = KD2 = KD3 = KD4 = KD, and 
the Popen (here, PAOA) is given by:
 
++
θθ θ
AOA 2
DD
2
22 2
1
P= ,
2K K 1
1+
A A
 (9)
where A denotes the ligand concentration, and θ2 is the 
diliganded gating equilibrium constant. Eq. 9 is, of 
course, simply another way of writing Eq. 7, but this 
form is useful for comparison with the expressions cor-
responding to the models below.
If the two binding sites are different and indepen-
dent, then KD1 = KD4 = KDA and KD2 = KD3 = KDB, and 
the Popen is given by:
  =
+
++ +
θθ θ
AOA
DA DB DA DB
2
22 2
1
P,
(K K ) K K 1
1
A A
 (10)
where KDA and KDB are the ligand dissociation equilib-
rium constants from either binding site regardless of 
whether both or only one site is occupied.
Figure 14.  The total Popen and the ACh-
  diliganded, choline-diliganded, and hetero-
diliganded fractions. This fi   gure is similar 
to Fig. 13 but, here, the contributions of the 
three open confi  gurations to the total Popen 
are expressed as ratios (fractions). (A)   Total 
Popen (the same plot as in Fig. 13 A). (B) 
ACh-diliganded fraction = POA2/Popen. (C) 
  Choline-diliganded fraction = POB2/Popen. 
(D) Heterodiliganded fraction = POAB/
Popen. The maximum contribution of ACh-
choline heterodiliganded openings to the to-
tal Popen is  50%, and this fraction decreases 
steeply outside a narrow range of ACh-choline 
combinations.734 Muscle AChR KD for Choline
If the two binding sites are equivalent and interacting, 
then KD1 = KD2 = KMONO and KD3 = KD4 = KDOUBLY, and 
the Popen is given by:
  =
++ +
θθ θ
AOA
DOUBLY MONO DOUBLY
2
22 2
1
P,
2K K K 1
1
A A
 (11)
where KMONO is the ligand dissociation equilibrium con-
stant from either monoliganded receptor confi  guration 
(both confi  gurations are equivalent), and KDOUBLY is the 
ligand dissociation equilibrium constant from either 
site of the diliganded receptor.
Finally, if the two binding sites are different and inter-
acting, the Popen is given by:
  =
⎛⎞
++ + + ⎜⎟ θθ θ ⎝⎠
AOA
D3 D1 D3 D1
2
22 D 2 2
1
P,
KK K K 1
11
AK A
 (12)
where KD4 is expressed in terms of KD1, KD2, and KD3 
(KD4 = KD1KD3/KD2, from detailed balance).
The parameter estimates obtained using Eq. 12 (i.e., 
assuming that the binding sites are different and inter-
acting) were very sensitive to the initial guesses, and the 
three KD estimates (here, KD1, KD2, and KD3) had very 
large coeffi  cients of variation. The results of fi  tting the 
data with the other three models, using Eqs. 9–11, are 
summarized in Fig. 12 and Table II.
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